Stifel Keeps Buy Rating for Pyxis Oncology, PT Cut to $8

Tuesday, Mar 24, 2026 9:33 am ET1min read
PYXS--

Stifel Keeps Buy Rating for Pyxis Oncology, PT Cut to $8

Stifel Keeps Buy Rating for Pyxis Oncology, PT Cut to $8

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet